Certara, Inc. Profile Avatar - Palmy Investing

Certara, Inc.

Certara, Inc. provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access. It offers medicines to patients using biosimulation s…
Medical - Healthcare Information Services
US, Princeton [HQ]
CERT/Financial Reporting

Income Statements

6 Sheets · Starting from 2023
In Million USD. Margins, Growth Rates In %
Metric 2018 2019 2020 2021 2022 2023
Revenue
163.00 208.00 243.00 286.00 335.00 354.00
EPS
-0.25 -0.06 -0.32 -0.09 0.09 -0.35
Profit
92.00 128.00 142.00 174.00 203.00 167.00
Pre Tax
-32.00 -9.00 -50.00 -3.00 18.00 -55.00
ETR
-2.14 2.46 1.56 -293.07 21.46 -0.39
Net
-33.00 -8.00 -49.00 -13.00 14.00 -55.00
EBITDA
32.00 60.00 17.00 58.00 88.00 70.00
Operating Income
-4.00 19.00 -24.00 13.00 32.00 14.00
Interest Income
- - 28.00 25.00 16.00 17.00 - -
Loss
-168.00 -188.00 -267.00 -272.00 -303.00 -340.00
Cost of Revenue
-71.00 -79.00 -100.00 -111.00 -132.00 -186.00
Operating Expenses
-97.00 -109.00 -167.00 -160.00 -170.00 -153.00
Depreciation and Amortization
-37.00 -41.00 -42.00 -45.00 -52.00 -56.00
Interest Expenses
-27.00 -28.00 -25.00 -16.00 -17.00 -22.00
Other Expenses
- - -28.00 -25.00 -16.00 -13.00 -69.00
WA Shares Outstanding
132.00 157.00 152.00 149.00 156.00 158.00
End of CERT's Analysis
CIK: 1827090 CUSIP: 15687V109 ISIN: US15687V1098 LEI: - UEI: -
Secondary Listings
CERT has no secondary listings inside our databases.